HEALTH NEWS
Study Title:
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
Study Abstract
At the moment, scientists are frantically trying to develop either a definitive cure, neutralizing antibodies, or a vaccine to protect us from contracting the disease in the first place, and they want it right now. We must consider that finding a vaccine for a disease may normally take years. There are reasons for all the precautions involved in developing a vaccine, not the least of which are unwanted side-effects. In light of the information discussed above about the cross-reactivity of the SARS-CoV-2 proteins with human tissues and the possibility of either inducing autoimmunity, exacerbating already unhealthy conditions, or otherwise resulting in unforeseen consequences, it would only be prudent to do more extensive research regarding the autoimmune-inducing capacity of the SARS-CoV-2 antigens. The promotion and implementation of such an aggressive “immune passport” program worldwide in the absence of thorough and meticulous safety studies may exact a monumental cost on humanity in the form of another epidemic, this time a rising tide of increased autoimmune diseases and the years of suffering that come with them.
Study Information
Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24. PMID: 32461193; PMCID: PMC7246018.Full Study
https://pubmed.ncbi.nlm.nih.gov/32461193/Recent News
Behind the Buzz: Alcohol’s Hidden Impact on Gut Health
Quercetin Phytosome & Luteolin: Dynamic Duo for Immune Health and Longevity
Nerve Nutrients for Comfort, Balance, and Neuroprotection
The Power of PEA: Feel Better, Think Sharper, Sleep Deeper
Collagen Peptides and Keratin: Building Blocks for Joints, Bones, and Skin